Sucroferric Oxyhydroxide
Save $504/mo
35× cheaperVelphoro is indicated for the control of serum phosphorus levels in adults and pediatric patients 9 years of age and older with chronic kidney disease (CKD) on dialysis.
United States
$519
per month
India
$15
per month
You save
−97%save $504/mo · 97% cheaper
157K US scripts/yr$79.1M potential annual savings$81.4M US spend/yr
Drag to rotate · 3D structureC12H29Fe5Na2O23
SMILES: C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3]
Compare the price
US price$519per month
India price$15per month
You save$50497% less
Based on 30 units per month. US $17.29 vs India $0.49 per unit.
Total over 1 periodSave $504$519 → $15
The bigger picture
Sucroferric Oxyhydroxide is filled about 157K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$81.4M
If sourced from India
$2.3M
Potential annual savings
$79.1M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.